Australia markets close in 31 minutes

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.23+0.87 (+2.10%)
At close: 04:00PM EDT
42.00 -0.23 (-0.54%)
After hours: 05:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.46B
Enterprise value 2.25B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.74
Price/book (mrq)4.39
Enterprise value/revenue 8.13
Enterprise value/EBITDA -35.26

Trading information

Stock price history

Beta (5Y monthly) 1.63
52-week change 3178.01%
S&P500 52-week change 326.14%
52-week high 350.50
52-week low 314.29
50-day moving average 336.09
200-day moving average 329.40

Share statistics

Avg vol (3-month) 3948.2k
Avg vol (10-day) 3945.41k
Shares outstanding 558.23M
Implied shares outstanding 658.23M
Float 857.34M
% held by insiders 11.75%
% held by institutions 1112.88%
Shares short (30 Apr 2024) 411.93M
Short ratio (30 Apr 2024) 413.81
Short % of float (30 Apr 2024) 426.81%
Short % of shares outstanding (30 Apr 2024) 420.49%
Shares short (prior month 28 Mar 2024) 412.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -69.24%
Operating margin (ttm)-64.92%

Management effectiveness

Return on assets (ttm)-15.63%
Return on equity (ttm)-30.40%

Income statement

Revenue (ttm)277.49M
Revenue per share (ttm)4.83
Quarterly revenue growth (yoy)25.10%
Gross profit (ttm)N/A
EBITDA -161.18M
Net income avi to common (ttm)-192.14M
Diluted EPS (ttm)-3.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)293.34M
Total cash per share (mrq)5.04
Total debt (mrq)89.42M
Total debt/equity (mrq)15.96%
Current ratio (mrq)5.51
Book value per share (mrq)9.63

Cash flow statement

Operating cash flow (ttm)-86.51M
Levered free cash flow (ttm)-32.77M